How China plans to ‘firmly rank at the global forefront’ with 25% of first-in-class drugs

China has set its sights on becoming a global biomedicine powerhouse by 2030, targeting key technological breakthroughs and at least a quarter of the world’s first-in-class drugs market under a new five-year plan for the sector. By the end of the decade, China would “firmly rank

KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.